Create Alert
Watchlist

Bafna Pharmaceuticals

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹212Cr
ROE7.43%
P/E Ratio(TTM)50.93
EPS(TTM)1.76
P/B Ratio2.50
Dividend Yield0.00%
Industry P/E43.26
Book Value35.85
Debt to Equity0.33
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing finished pharmaceutical formulations. It is also involved in manufacturing 336 licensed pharmaceutical formulations and has globally registered approximately 78 of its products. Its Madhavram facility manufactures finished solid oral and liquid oral dosage forms of Betalactam and Non-Betalactam and Cephalosporin products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements.;
Parent OrganisationBafna Pharmaceuticals
Managing DirectorNA
NSE SymbolBAFNAPH

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
75.00%
Retail And Others
16.47%
Foreign Institutions
8.53%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
61.31
Ajanta Pharma
NA
(0.00%)
37.82
Gland Pharma
NA
(0.00%)
46.48
Eris Lifesciences
NA
(0.00%)
68.64